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Abstract: Syndromic surveillance has, so far, considered only simple models for Bayesian in-
ference. This paper details the methodology for a serious, scalable solution to the problem of
combining symptom data from a network of U.S. hospitals for early detection of disease outbreaks.
The approach requires high-end Bayesian modeling and signiﬁcant computation, but the strategy
described in this paper appears to be feasible and oﬀers attractive advantages over the methods
that are currently used in this area. The method is illustrated by application to ten quarters worth
of data on opioid drug abuse surveillance from 636 reporting centers, and then compared to two
other syndromic surveillance methods using simulation to create known signal in the drug abuse
database.
1 Introduction
There is enormous social beneﬁt from early discovery of disease. Quick detection of emerging
geographical clusters of disease has important beneﬁts for public health; swift intervention can
prevent a pandemic. The stakes are immense: the US congressional Oﬃce of Technology Assessment
estimates that a release of 100 KG of anthrax spores upwind of Washington, DC, would, if not
detected rapidly, lead to as many as three million deaths and nearly a trillion dollars of life and
economic loss (Goldenberg et al., 2002).
However, the ﬁrst few cases of a disease are easy to overlook, since they may be misdiagnosed
as atypical presentations of a relatively benign illness or isolated cases caused by rare transmis-
sion vectors. Deﬁnitive diagnoses, especially of rare diseases, require time. To overcome the lag
implied by traditional public health notiﬁcation structures based on ﬁnal diagnoses, the Depart-
1ment of Homeland Security and the Centers for Disease Control have discussed implementation of
a monitoring system in which all hospitals in the United States report, in real or near-real time,
admissions and out-patient visits associated with several kinds of symptoms. The expectation is
that an outbreak of, say, anthrax will be visible ﬁrst as a regional up-tick in the number of people
treated for severe coughs, or that epidemic ﬂu is signaled by a surge in patients with fever.
The statistical theory and methodology underlying a successful syndromic surveillance system
must satisfy many criteria. Speciﬁcally, the system must:
1. Be Scalable. Scalability requires that the method be computable, in appropriate time, on
datasets of the size expected for disease surveillance. Ultimately, an eﬀective program would
link all major U.S. hospitals into the reporting network. This implies data from about 7,500
hospitals.
2. Be Multivariate. The input data will be in terms of multivariate counts; hospitals will report
admissions according to syndromic categories, such as fever, cough, rash, and combinations
of these. Such counts are not independent. When there are additional sources of data, more
subtle dependencies can arise. For example, there is overlap between the people absent from
work and those purchasing over-the-counter medications, and both kinds of data have been
proposed as useful data sets for an integrated syndromic surveillance system. A successful
system must handle multivariate inference.
3. Incorporate Covariates. Diﬀerent geographical regions have diﬀerent disease proﬁles. Hos-
pitals in Miami, FL service an elderly population, and will tend to report diﬀerent kinds of
illnesses. Less aﬄuent populations make greater use of emergency room facilities. Statistical
analysis must account for demographic information such as the size of the local population,
its age structure, and perhaps local temperature or pollution levels (Dominici et al., 2006).
4. Change with Time. There are well-known weekly and daily patterns in hospital admissions
and emergency room visits, as well as seasonal trends in disease, short-term demographic
changes (e.g., summer vacation in college towns), all of which must be accounted for when
distinguishing bioterrorism from natural outbreaks from random ﬂuctuation.
5. Accommodate Low Quality Data. Data quality is a complex, multi-faceted issue (Karr et al.,
2006). The multiplicity of sources requires particular attention to data quality issues.
26. Support Decision-Makers. In order to be a usable real-time tool, a syndromic surveillance
system must produce easily interpretable results. Especially given public, media and political
hypersensitivity about disease outbreaks, false alarm rates must be low, and also commen-
surate with the resources available for post-signal investigation. To enable conﬁdence, the
modeling in the system must be understandable, at least at a heuristic level.
Statistically, the unifying theme for these criteria is principled calculation of uncertainties.
Satisfying these criteria poses daunting challenges, leading to the arrival of syndromic surveil-
lance as a new interdisciplinary research area. No current approach to syndromic surveillance
satisﬁes all (or even most) of these requirements.
As with many ﬁelds, syndromic surveillance has grown opportunistically. Initial work relied
heavily upon oﬀ-the-shelf statistics, such as CUSUM charts (CDC), regression and exponentially
weighted moving averages (the RODS project), and standard time series models (Burkom, 2003).
Some “cocktail” approaches were developed, such as a combination of time series and control charts
for early detection of anthrax outbreaks by tracking over-the-counter medication sales (Goldenberg
et al., 2002). The most statistically advanced procedures involve the spatial scan statistic (Kulldorﬀ,
1997) which counts the number of disease reports in a given geographic window (for instance, a
circle of ﬁxed radius) and then “slides” that window over the region to determine whether there is
any center-point whose window contains a count that is signiﬁcantly higher than expected under the
null model of no epidemic. This was extended to detect space-time clustering of disease (Kulldorﬀ
et al., 1998), allowing one to ﬁnd hotspots that are concentrated in time as well as space. Further
extensions are given by Assuncao et al. (2006), Costa and Assuncao (2005), Duczmal and Assuncao
(2004), Duczmal et al. (2006), Kulldorﬀ et al. (2003) and Kulldorﬀ et al. (2006). These methods
require some work to establish the null distribution of their test statistics; permutation methods are
often used, but these make independence assumptions that are problematic for contagious disease.
These methods use classical frequentist statistics, and consequently suﬀer from issues of multiple
testing, interpretability of results, high false alarm rates versus low power, and inadequate use of
covariate information. Only initial work has been done from a Bayesian perspective; Neill et al.
(2005) and Neill et al. (2006) describe an elementary model with convenient priors, but do not draw
upon the full power of Bayesian hierarchical models for complex spatial and temporal dependence,
nor do they address the need for ﬂexible models that incorporate essential covariate information
3on population size and seasonality. For these and other reasons, all previous work in this area fails
on at least one of ﬁve criteria that we have listed.
To address these shortfalls, Section 2 lays out a sophisticated, fully Bayesian approach to
syndromic surveillance for disease outbreaks. Section 3 applies that methodology to the problem
of drug abuse surveillance; our dataset and model are slightly smaller and simpler than is needed
for national hospital surveillance, but we establish feasibility and highlight practical issues. Section
3 also compares the CAR results to surveillance systems based on CUSUM charts and paired
comparisons. Section 4 discusses the results, and indicates the technical extensions that are needed
to address large-scale problems.
2 Bayesian Syndromic Surveillance
Bayesian models for spatial and spatio-temporal processes have become prominent in applied statis-
tics (Besag, 1974, 1975; Carlin and Banerjee, 2003; Banerjee et al., 2004; Sahu et al., 2006).
These models pose special computational issues, and each application requires individual mod-
eling. Nonetheless, there is growing consensus in the applied statistics community that when such
models are carefully constructed and tested, they represent a powerful approach to big, important
problems.
We propose a hierarchical model for the disease reporting process. At the bottom level of the
hierarchy are vectors of counts from each hospital of patients with speciﬁc symptoms. Above that
level, the spatial structure is determined by a graph whose vertices are hospitals and whose edges
link “cliques” of hospitals that are suﬃciently close to experience a common outbreak. Similarly,
the temporal structure is determined by dependence of the reported counts upon previous reports
from the same hospital and those to which it is connected in the graph. At the top level of
the hierarchy, one has general location eﬀects. Such systems are called conditional autoregressive
models, or conditional autoregressive (CAR) models.
CAR models have their roots in the Ising models of physics, now generalized as Markov random
ﬁeld models. Inference is done through Markov chain Monte Carlo (MCMC), but problems of the
scale considered in this application pose signiﬁcant computational challenges. The research issues
in the model and the computation are described in the following subsections.
42.1 The Basic Model
For clarity, we start with a simple case, assuming univariate reports on a single symptom (say,
fever), a simple ARMA model for the noise term in the model for fever counts, and covariates that
are measured without error.
The measurement at hospital i on day t is Yi(t)—the number of reported patients who have,
say, high fevers. We suppose that there are m hospitals and T days of data. From epidemiological
considerations, for most diseases the signals will manifest within 7 to 14 days.
To start, we assume that the number of cases Yi(t) at hospital i on day t has a Poisson distri-
bution. (This can be extended to the more realistic case of multivariate records and extra-Poisson
variation.) In the absence of an epidemic, the mean function of the Poisson count at hospital i is
µi(t); when there is a disease, there are additional cases and the mean of the additional count is
λi(t). An indicator function δi(t) marks whether a disease is present. Thus the model for the data
at hospital i is:
Yi(t) ∼ Pois(µi(t) + δi(t)λi(t)). (1)
Using this, we want to make an inference about the probability that one or more of the δi(t) are
non-zero, i.e., the posterior probability that there has been a disease outbreak.
We can compute the posterior probability for a well-constructed hierarchical Bayes model; the
ﬁrst stage of this model is based on the Poisson distribution speciﬁed by equation (1). The spatial
dependence is captured through the CAR model. Unlike the scan statistic, our models can easily
and directly incorporate additional covariate information. Also unlike the scan statistic, which
concentrates on ﬁnding only the primary cluster, and occasionally, secondary cluster(s), our method
identiﬁes all important regions and time windows based on the posterior distribution of relevant
model parameters. Indeed, as in any realistic Bayesian application, our Bayesian inference is driven
by posterior summaries of relevant model parameters. Such summaries are obtained via MCMC.
In particular, we rely on Gibbs sampling (Gelfand and Smith, 1990) and the Metropolis-Hastings
algorithm (Metropolis et al., 1953; Hastings, 1970).
The model given by (1) is obtained by extending Scott and Berger (2006), where the goal is to
test which of many normal populations have zero means. That study is motivated by the need to
analyze DNA microarray data, for which the expression level for most genes is assumed to be zero
Scott and Berger (2006); that view accords with disease surveillance, since one assumes that nearly
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are drawn from a N(δiµi,σ2) distribution, i = 1,...,n, where the δi’s are i.i.d. Bernoulli random
variables with parameter p. The objective is to determine which of the means are zero. A zero
mean is equivalent to the corresponding δi being zero. Priors are placed on the µi and p. Their
study found that the Bayesian procedure introduces a penalty that adjusts for multiple testing.
In particular, the posterior probability of δi = 1 “decreases as the number of ‘noise’ observations
grows, so that the same observation is viewed as implying less evidence of a non-zero mean when
more tests are simultaneously considered”.
We now discuss possible models for the parameters µi(t), λi(t) and δi(t). These adapt models
used in the disease mapping literature (Clayton and Bernardinelli, 1992; Carlin and Banerjee, 2003;
Datta et al., 2000; Tsutakawa, 1988; Waller et al., 1997b), statistical image analysis (Besag, 1974,
1986; Hogmander and Moller, 1995), and models used in small area estimation that incorporate a
cross-sectional and time series approach (Datta et al., 1999; Ghosh et al., 1996; Pfeﬀermann and
Burck, 1990; Rao and Yu, 1994). While we need to be fairly speciﬁc in modelling µi(t) and δi(t),
we can be less speciﬁc, for reasons explained later, in modeling λi(t).
2.1.1 Modeling µi(t)
Let θi(t) = log(µi(t)). We use the representation θi(t) = XT
i (t)β+ξi(t), where the covariate vector
Xi(t) for hospital i at time t is included to capture seasonality and day-of-week eﬀects, as well as
weather and holiday-related covariates that aﬀect the baseline rate. In this representation of θi(t)
one can include a ﬁxed “oﬀset” term to account for the known base population.
We consider a series of multivariate normal models for the ξi(t)’s:
Model 1: Let ξi(t) = ψi + γt. Here the spatio-temporal eﬀect is expressed through an additive
model. To explain spatial dependence, we employ a CAR model for ψ = (ψ1,...,ψm)T as in,
for example, Besag (1974) and Clayton and Kaldor (1987). One possible model for γt is an
AR(1) model.
Model 2: We assume a joint normal distribution and specify certain conditional mean and vari-
ance functions. Let E[ξi(t)|ξj(t), j  = i, ξ(s), s < t] = ρ1
 
j wijξj(t) + ρ2ξi(t − 1), and
Var[ξi(t)|ξj(t), j  = i,ξ(s), s < t] = σ2, where ξ(t) = (ξ1(t),...,ξm(t))T and W = (wij),
the adjacency matrix correlating neighboring hospitals. As a ﬁrst step, the elements of W
6are taken to be 1 if hospitals i and j are neighbors, and zero otherwise. In an alternative
model, wij can depend on the geographical distance and other measures of proximity, but
that requires much more computation. From the conditional mean and variance speciﬁcation
above, it is possible to get the mean and the variance of the joint multivariate distribution
after appropriate modiﬁcation of the argument in Rao (2003, p. 208) or Carlin and Banerjee
(2003).
Model 3: Let ξi(t) = vi + hi(t), where v = (v1,...,vm)T, hi = (hi(1),...,hi(T))T, and h =
(hT
1 ,...,hT
m)T. Here we put independent prior distributions on the random components v
and h. For a simple model, we can assume that components v1,...,vm which capture random
eﬀects due to the hospitals are independent and identically normally distributed as is often
assumed in small area estimation (Datta and Ghosh, 1991; Datta et al., 2005; Prasad and
Rao, 1990; Rao, 2003). However, since spatial dependence is expected in the hospital random
eﬀects, a better option would be to replace the i.i.d. assumption by a CAR model as developed
for disease mapping (Clayton and Kaldor, 1987; Rao, 2003). While systematic trends in the
time series variation in the longitudinal data can be explained through the covariate vector,
the random vector h can be modeled as in Datta et al. (1999) to account for dependence in
the series of observed counts.
To complete a hierarchical Bayesian formulation, we need to specify appropriate priors, pos-
sibly diﬀuse, on β and parameters, termed hyperparameters, that appear in the distribution of
ξi(t). For example, as part of the ﬁrst model, we assume independent Gaussian distributions for
{ψi, i = 1,...,m} and {γt, t = 1,...,T}. We specify appropriate priors on β and hyperparameters
appearing in the CAR model for ψ (Ghosh et al., 1996) and an AR(1) model (see Ghosh et al.
(1996) for an application) or a random walk model (see Datta et al. (1999, 2002) for applications)
for the γ’s.
2.1.2 Modeling λi(t)
We could model log(λi(t)) in a similar fashion as described for log(µi(t)). One might ﬁt a separate
form of λi(t) for each possible disease, taking account of its virulence, incubation period, and so
forth; or one might ﬁt a smoothed impulse function, to account for exposure to non-contagious
pathogens, such as an anthrax release.
7However, the reality is that in a syndromic surveillance system, the inference should not be
sensitive to the shape of the epidemic curve. One just needs λi(t) to be an increasing function over
the ﬁrst few days of the disease. At that point, the syndromic surveillance system signals, public
health oﬃcials intervene, and the model for the shape of the epidemic curve becomes largely irrele-
vant as medical intervention and behavioral changes quickly invalidate any standard mathematical
model.
For this reason, modeling λi(t) is relatively easy, compared to other terms in the CAR model.
We believe it is suﬃcient to take it as a linear function of time with moderate slope. Anything
more dramatic than that will be quickly detected by the model, since the signal will seem very
strong compared to the gradual increase that the model is tuned to discover.
2.1.3 Modeling δi(t)
The δi are the basis for the spatial portion of the syndromic surveillance system. Since the δi(t)’s
are binary variables, as a ﬁrst step we assume these are independent random variables that are
1 with probability pi(t). Then, we create dependence among the δi(t) through linear modeling of
logit(pi(t)), by means of an increasing function of the number of neighboring hospitals in which a
disease outbreak is present. Weights are likely to depend upon distance, but could reﬂect demo-
graphic information and commuter patterns, although the latter would probably require weights
that are functions of time.
Much more generality is possible, and some of it may be useful. In particular, it would be
natural to describe the joint distribution of the δi(t)’s as a binary Markov random ﬁeld. The ﬁeld
is deﬁned by an undirected graph where the state of the node indicates whether the syndrome is
absent or present. This could extend further to a k-state model in which the level of the state
indicates the severity of the syndrome at a node. The neighborhood structure for the ﬁeld is given
by the graph.
For the syndromic surveillance system, each hospital is connected in a graph to nearby hospitals.
The hospitals form a connected graph with nodes {ν1,...,νm}. Let A = [aij] be the adjacency
matrix of this network, such that aij = 1 if and only if there is an (undirected) edge between νi
and νj. We assume that every hospital is connected to itself, so aii = 1 for i = 1,...,m. In this
network, the node-set K = {νi1,...,νik} is a clique if aij = 1 for all i,j ∈ K, which one can think
8of as all the hospitals in a given city. Also, let K denote the set of all cliques in the network.
This network is extended to incorporate time as follows. Let {ν1(t),...,νm(t),t = 1,...,T} be
a network with adjacency matrix given by
A(1,...,T) =


 
 
 
 
 

 
 

A Im 0 0     0
Im A Im 0     0
0 Im A Im     0
. . .
0     Im A Im 0
0     0 Im A Im
0     0 0 Im A


 
 
 
 
 

 
 

,
where Im is the identity matrix of size m. That is, the neighbors of node νi(t) are other nodes at
time t, as well as itself in the immediate past and present (with directed edges), or νi(t − 1) and
νi(t + 1). The cliques of this extended network are as follows. If K = {νi1,...,νik} is a clique
then K(t) = {νi1(t),...,νik(t)} is also a clique, for t = 1...,T. Also, {νi(t),νi(t + 1)} lie within a
clique, for i = 1,...,m, t = 1,...,T − 1. Since the start of an epidemic occurs over a ﬁnite time
horizon of duration h, we need only consider networks with adjacency matrix A(t,...,t + h).
The syndromic surveillance model assumes that there is a latent indicator variable δi(t) associ-
ated with each node. Let D = {0,1}mT, that is, the set of all possible conﬁgurations of the latent
indicators. Grimmett (1973) showed that any joint distribution with positive probability on every
point in D and the Markov random ﬁeld property has the following probability mass function
p(δ(t),t = 1,...,T) =
1
Z(φ)
exp
 
T  
t=1
 
K∈K
φK(t)
 
i∈K
δi(t) +
T−1  
t=1
m  
i=1
ωi(t)δi(t)δi(t + 1)
 
,
where Z(φ) is a normalizing constant that depends upon node interactions. This expression builds
on earlier work by Besag (1974), Hammersley and Cliﬀord (1971), and Spitzer (1971). The joint
distribution is referred to as a Gibbs measure for the Markov random ﬁeld. Note that the summation
over the cliques enables a much more tractable expression than if clique structure were not available.
Exploiting the clique structure, the Gibbs measure can be rewritten as follows. Let φi1   ik(t)
9denote φK(t) if ij ∈ K,j = 1,...,k. Then
p(δ(t),t = 1,...,T) =
1
Z(φ)
exp
 
T  
t=1
m  
i=1
φi(t)δi(t) +
T  
t=1
 
{i,j}∈K
φij(t)δi(t)δj(t) (2)
+
T  
t=1
 
{i,j,k}∈K
φijk(t)δi(t)δj(t)δk(t) +    
+
T−1  
t=1
m  
i=1
ωi(t)δi(t)δi(t + 1)
 
.
In this representation, φi(t) is the main eﬀect for node i at time t, φij(t) is the 2-way interaction
between nodes i and j at time t, φijk is the 3-way interaction among nodes i, j and k at time t, and
so on; ωi(t) represents the interaction between node i and itself at times t and t + 1. The model
can be simpliﬁed by assuming that the parameters do not change over time, i.e., ωi(t) = ωi,φi(t) =
φi,φij(t) = φij, etc.
The formulation has analogies to complex systems of interacting components in reliability theory
(Durham and Lynch, 2000; Gleaton and Lynch, 2004). There the nodes indicate the state of
a component. As noted in Gleaton and Lynch (2004, 2006), the fundamental quantity for the
component is not the hazard function but the log odds ratio. Here, the conditional log odds ratio
li(t0) of δi(t0), given all the other indicators at time t0 (i.e., δ(i)(t0)) and all indicators for time
t = 1,...,t0 − 1, is described as follows. For this, let di(t0) denote (δ(t),t = 1,...,t0) with
δi(t0) = 1; let ¯ di(t0) = (δ(t),t = 1,...,t0) with δi(t0) = 0; and let δ(i)(t) denote δ(t) without the
ith element. Then
li(t0) = log
 
P(δi(t0) = 1|δ(i)(t0),δ(t),t = 1,...,t0 − 1)
P(δi(t0) = 0|δ(i)(t0),δ(t),t = 1,...,t0 − 1)
 
= log
 
p(di(t0))/p(δ(i)(t0),δ(t),t = 1,...,t0 − 1)
p
 ¯ di(t0)
 
/p(δ(i)(t0),δ(t),t = 1,...,t0 − 1)
 
= φi +
 
j:{i,j}∈K
φijδj(t0) +
 
j,k:{i,j,k}∈K
φijkδj(t0)δk(t0) +     + ωiδi(t0 − 1).
Gibbs sampling may be used to generate a sample from this joint distribution based only on these
conditional log odds ratios. To carry out fully Bayesian inference we assign a prior distribution on
the hyperparameter φ. Gibbs sampling then requires the full conditional distribution of φ (Gelfand
and Smith, 1990), which is proportional to the kernel of φ determined by the normalizing constant
Z(φ) above and the prior distribution on φ. Evaluation of the normalizing constant Z(φ) for a
10general Markov random ﬁeld, without which the posterior is intractable, is challenging (Hoeting
et al., 2000).
One practical simpliﬁcation is to use empirical Bayes, and substitute the maximum likelihood
estimate of φ), although even this is not straightforward (Hogmander and Sarkka, 1999). Alter-
natively, things can be kept at a manageable level by means of the hierarchical network structure
explained in section 2.1.6. Because of the hierarchical structure, the number of cliques in a Markov
random ﬁeld network will be substantially fewer, and for such sparse matrix cases we can com-
pute the normalizing constant Z(φ) symbolically. In addition, it is reasonable to assume a ﬁnite
discrete prior distribution on the φ’s for each node of the network, which greatly reduces the com-
puting time. Depending upon the scale of the application, one could consider richer classes of prior
distributions for φ.
2.1.4 Choice of φ
For the Bayesian model one is interested in the posterior of the vectors of latent variables δ given
the vector of counts y. In the construction of the prior needed to get the posterior there are a
number of practical issues. Since the latent variables are considered alarms or signals, we should
not raise any alarms when there is no data. Hence, the prior probability of all the latent variables
being zero should be high or close to one. This can be accomplished by putting substantial prior
weight on large negative main eﬀects. However, if the main eﬀects are chosen to be −∞, there
would be no power to detect an anomaly.
The interaction terms tells us how strong the dependencies are between nodes. If all interactions
are zero, then the nodes would be independent. For disease spread, a node being “on” (i.e., 1) would
increase the likelihood that its neighbors are “on” or will soon be turned “on”. Hence, the 2-way
interactions should be positive. How large they are will depend on things such as the volume of
car or air traﬃc between nodes, distance, amount of patient exchange, and so forth.
2.1.5 Posterior Distribution
Next, the posterior distribution of δ(t) given the observed counts y(t) is described. This is the
object of primary interest. If the posterior probability that a component of this vector is equal to 1
is large, then the corresponding region appears to be undergoing an epidemic outbreak. How large
11this posterior probability should be in order to trigger attention is a matter of decision theory, and
the probabilistic output directly supports such management; one calculates the expected loss from
action and inaction, and then makes the best decision.
Our inference on δ(t) is driven by the posterior probabilities of δ(t), computed from Gibbs
samples. For Gibbs sampling we need the full conditional distribution of δ(t). For this, note that:
p(y(t)|δ(t), t = 1,...,T)
=
m  
i=1
(µi(t) + δi(t)λi(t))yi(t)e−µi(t)−δi(t)λi(t)
yi(t)!
=
exp[
 m
i=1 yi(t)log(µi(t) + δi(t)λi(t)) − µi(t) − δi(t)λi(t)]
 m
i=1 yi(t)!
=
exp
  m
i=1 yi(t)
 
δi(t)log(1 +
λi(t)
µi(t)) + log(µi(t))
 
− µi(t) − δi(t)λi(t)
 
 m
i=1 yi(t)!
= c(y(t),µ(t))exp
 
m  
i=1
 
yi(t)log(1 +
λi(t)
µi(t)
) − λi(t)
 
δi(t)
 
.
Using this last expression and (2), and assuming that the counts are conditionally independent
given the indicator variables, the distribution of (δ(t),t = 1,...,T) given (y(t),t = 1,...,T) is
p(δ(t),t = 1,...,T|y(t),t = 1...,T) ∝ p(δ(t),y(t),t = 1,...,T)
= p(δ(t),t = 1,...,T)
T  
t=1
p(y(t)|δ(t),t = 1,...,T)
= c(y(t),µ(t),t = 1,...,T)exp
 
T  
t=1
m  
i=1
 
yi(t)log(1 +
λi(t)
µi(t)
) − λi(t)
 
δi(t)
 
×
1
Z(φ)
exp


T  
t=1
m  
i=1
φiδi(t) +
T  
t=1
 
{i,j}∈K
φijδi(t)δj(t)
+
T  
t=1
 
{i,j,k}∈K
φijkδi(t)δj(t)δk(t) +     +
T−1  
t=1
m  
i=1
ωiδi(t)δi(t + 1)


∝ exp


T  
t=1
m  
i=1
 
φi + yi(t)log(1 +
λi(t)
µi(t)
) − λi(t)
 
δi(t) +
T  
t=1
 
{i,j}∈K
φijδi(t)δj(t)
+
T  
t=1
 
{i,j,k}∈K
φijkδi(t)δj(t)δk(t) +     +
T−1  
t=1
m  
i=1
ωiδi(t)δi(t + 1)

;
that is, the posterior distribution has the same form as the prior, with the same interaction parame-
ters, but with main eﬀect parameters φ′
i(t) = φi+yi(t)log(1+λi(t)/µi(t))−λi(t), i = 1,...,m, t =
121,...,T.
Notice that φ′
i(t) increases as the count yi(t) increases. Also notice that φ′
i(t) is larger than φi
only if yi(t) > λi(t)/log[1 + λi(t)/µi(t)].
2.1.6 Hierarchical Structure of the Network
Simpliﬁcation occurs in the Gibbs measure by considering a hierarchical structure for the graph.
For example, consider a hub-feeder network.
This network can be used recursively to build large Markov random ﬁelds where there are
dependencies between nodes but many nodes are conditionally independent given their predecessors
in the hierarchical structure of the network. In particular, a geographical region can be divided into
subregions. Major nodes in the various subregions will be designated level 1 hubs while the other
nodes are now subdivided into further subregions. Major nodes in these subregions are designated
as level 2 hubs but are feeders into the level 1 hubs. Continuing in this fashion we have a series of
level 1 to level k hubs where at level k the nodes that have not been designated as hubs are feeders
into the various k-level hubs. The model we consider here is one in which the non-hub nodes are
feeders into only the level-k hubs. This model is illustrated in the ﬁgure below.
Figure 1: A hub-feeder network that permits a relatively simple hierarchical model for syndromic
surveillance data.
13The advantage of this model is that it is recursive, which simpliﬁes the dependency structure of
the joint distribution (the Gibbs measure) for the Markov random ﬁeld. Thus one can model each
level in the same way, using a common hyperprior and block-diagonal matrices for the covariance
structure.
Alternative models are possible. The most interesting speciﬁcation uses dynamic networks.
These are more realistic but also more complicated. The ideas in Banks et al. (2008) provide an
entry point to this line of investigation.
2.2 Extending the Basic Model
The basic model does not yet satisfy all of the criteria for a surveillance system that are listed in
Section 1. In particular, two signiﬁcant extensions are needed to accommodate multivariate counts
and data quality issues. These extensions will be complex in practice, but we believe that they are
technically feasible and can be achieved incrementally.
2.2.1 Multivariate Counts
Hospitals record counts for symptoms such as fever, cough and rashes, all of which are symptoms
of more than one disease. When there is an upswing in a particular disease, these separate counts
will increase in a fashion that reﬂects the dependency among the symptoms characterizing the
syndrome that is associated with the disease. We model this scenario by the hierarchical Bayes
model described below. For simplicity, we consider a bivariate setup where counts of two symptoms
are recoded and both symptoms are indicative of the same disease.
Model:
• Conditional on µi1(t), µi2(t), δi(t),λi1(t), and λi2(t), the Yi1(t), Yi2(t) are independent Pois-
son random variables with means µi1(t) + δi(t)λi1(t) and µi2(t) + δi(t)λi2(t), respectively;
• Each component mean µi1(t), µi2(t) is modeled in the same way as described for µi(t) in in
section 2.1;
• δi(t) is modeled as in section 2.1;
• Each of λi1(t), λi2(t) is modeled as described for λi(t) in section 2.1.
14One completes the model speciﬁcation by suggesting prior distributions on the hyperparameters
that appear in the distributions of µi1(t),µi2(t),λi1(t),λi2(t) and δi(t). The inference is based on
the posterior probability of δi(t) = 1.
In practice, numerous syndromes, say Ai1,Ai2,...,Aig, are monitored and counts of these syn-
dromes, Yi1(t),Yi2(t),...,Yig(t), are recorded at hospital i. For simplicity we assume that these
syndromes are disjoint from one another. (If not, the syndromes can be combined and labeled to
account for this.) We assume that these counts are independent Poisson random variables with
means µij(t) + δij(t)λij(t).
2.2.2 Data Quality
In any real-world application, the quality of the data reported from the hospitals will be suspect.
We describe a two-tier system of analysis that maps known characterizations of data quality into
ﬁnal estimates of uncertainties.
The ﬁrst tier treats the data as if they were correct, and performs the MCMC updating to ﬁnd
the posterior probability that one or more hospitals is experiencing a public health emergency.
When a hospital or a set of hospitals appears to signal, the second tier of analysis is used. This
tier incorporates, for example, a heavy-tailed error model for the data, built to reﬂect data entry
error, misdiagnosis or over-diagnosis, conﬂated symptom categories, and so forth. The point of the
second tier analysis is to determine whether there is a single report (or small number of reports)
that account for nearly all the signal. If that is the case, as opposed to seeing an alarm that is
robustly dependent upon separate reports, then the decision-maker should be more conservative in
managing the response.
This kind of assessment might be relatively informal; perhaps a phone call with the hospital
administrator would obviate the need for mathematically athletic analysis. But we note that, if
full calculation is done, it could be done locally, and would not pose the scalability issues that arise
in the more elaborate model that was previously discussed. Tools and approaches outlined in Karr
et al. (2006) may also be used to incorporate external and domain knowledge of data quality into
the quality assessment.
152.2.3 Other Extensions
Additional extensions necessary for practical applications to disease surveillance using hospital
reports include:
• Use of covariate information and Bayesian updating to handle slow drift in the local baseline
rates, such as might be due to immigration or pollution trends.
• Use of contextual information to downweight spurious signals from innocent causes, as might
happen if one hospital closes and thus the reporting rates at neighboring hospitals jump.
• Modeling of abrupt noncontagious change (anthrax aerosol) versus slow/fast spread of a
contagious disease—this will aﬀect how quickly the signal emerges.
• Handling of extra-Poisson variation, which would naturally arise if the background rate were
spiked by occasional situations in which a large family all became sick, or a group of co-
workers were exposed to an unusually infectious strain; see Dey and Ravishanker (2000) and
Martin (2003) for Bayesian treatments of overdispersion in generalized linear models.
• Multiple geographies. While it is sensible as an entry point to the research, as in section 2.1.6,
to posit a graph structure for hospitals that reﬂects geographical proximity, this may fail to
capture important dependencies in the data. For instance, a workplace-induced outbreak may
be most visible in the hospitals associated with the employer’s health beneﬁts plan, which
are distributed rather than adjacent in space.
• At this point, it is simply unclear to what extent data conﬁdentiality issues will impact the
use of syndromic surveillance systems. While there is clear social beneﬁt from the early
detection of disease outbreaks, there are counter-balancing considerations of both individual
and organizational privacy that may inﬂuence the kinds of analysis that can be performed.
In order to actually ﬁt a model of this kind in practice, model-checking steps would be needed to
identify which systematic inaccuracies of this kind that require further adjustments. Some of these
checks are indicated in the following section.
163 Drug Abuse Surveillance: An Application
Data on abuse of prescription opioid analgesics oﬀers an opportunity for comparing syndromic
surveillance methods (Compton and Volkow, 2006). Prescription drug abuse has similarities to
infectious disease due to the inherent geographical eﬀects (Cicero et al., 2005), multiple reporting
systems which vary in coverage and data quality, and the fact that it is a major concern for public
health management. Prescription opioid analgesic abuse costs the U.S. an estimated $8.6 billion in
2001 due to increased health care, workplace, and criminal justice costs (Birnbaum et al., 2006).
This section uses data from the Researched Abuse, Diversion, and Addiction-Related Surveil-
lance (RADARS R  ) system. In particular, we use the Opioid Treatment Programs (OTP) study,
which collects questionnaires on a quarterly basis from abusers enrolled in Methadone Maintenance
Treatment Programs (MMTPs) and thus captures a sentinel population of sophisticated abusers.
We further focus on the opioid analgesic OxyContin R   (oxycodone HCI, controlled-release) Tablets,
since it has been the target of abuse over several years Carise et al. (2007). Using this data, we ﬁt a
CAR model of the kind described in Section 2, and then compare the performance of that model to
two other methods used in syndromic surveillance: CUSUM charts and paired-diﬀerence studies.
The comparison is based on the power of the three procedures for detecting change (a decrease)
in abuse rates. The power simulation uses the OTP data as the baseline (to ensure realistic
complexity in the correlation structure of the reporting centers and heteroscedasticity in the center
rates), and ﬁts a generative CAR model to these data. That model is then used to simulate OTP
data corresponding to prescribed percentage reductions in the overall abuse rate. The methods are
compared in terms of their power to detect small changes.
3.1 A CAR Model for Drug Abuse Surveillance
In this application we modify the model in (1) to reﬂect the emphasis upon changing proportions
of opioid drug abusers at the MMTPs and the covariates available in the OTP data. Speciﬁcally,
we use a logit (log odds) model instead of the Poisson response model, which stays within the
Generalized Linear Model family (McCullagh and Nelder (1989)); this linearizes the relationship
between the proportion of MMTP clients reporting opioid abuse and the covariate terms. Among
the covariates available from the OTP, our model incorporates age, gender, and race.
CAR models include spatial dependence via a neighborhood structure, so that reporting units
17that are near each other have correlated responses. In our application, there are known hot spots
of opioid drug abuse in Appalachia and Maine, which are fairly stable over the timespan of OTP
data (the third quarter of 2004 to the second quarter of 2006). In this analysis, we aggregated the
geographic information to the state level; it is coarse, but our results show that it is eﬀective.
Inference is done through Markov chain Monte Carlo (Waller et al., 1997a). Despite the rel-
ative simplicity of this application compared to disease surveillance, there are still computational
challenges. Using coarse geography enables our (unoptimized) code to execute within a few hours.
Finer resolution could require several days, unless one took systematic advantage of relatively so-
phisticated methods to accelerate the calculation. For similar reasons we do not attempt to ﬁt
a full spatio-temporal model, as described in Section 2. However, in the following subsection on
power comparisons we incorporate time dependence through a ﬁxed eﬀect term.
The CAR model used in this example is:
Yik(t) ∼ Bernoulli(pik(t))
logit(pik(t)) = β0 + β1xi1 + β2xi2 + β3xi3 + bk (3)
where Yik(t) is the outcome for individual i living in state k (i.e., it is 1 if the individual has used
an oxycodone product in the past month and 0 otherwise). The covariates describe gender, race,
and age, respectively, where race has been dichotomized to White or non-White and age has been
broken down into 17 ordered categories. Flat priors were used for all coeﬃcient parameters. The
spatial random eﬀects for U.S. states in the CAR model are assumed to have prior distribution
π(b1,...,bK) ∝ exp

−
τ
2
 
i =j
wij(bi − bj)2


where τ is the precision parameter, given a Gamma(1,1) prior, and wij is obtained from the matrix
of binary weights that indicate whether two states share a border. We examined the use of a
quadratic term in age, but it was not signiﬁcant and thus was excluded from this model.
Initial work also ﬁt linear and quadratic terms in time, to discover trends in the abuse rate.
The coeﬃcients on these terms were not (Bayesianly) signiﬁcant in any of the models (neither the
model with both terms, nor the models with each term separately). For this reason, the trend
component was excluded in ﬁtting the model described above. However, this same ﬁtted model,
but with a piecewise linear trend, is used in the next subsection to generate simulated data with
18Table 1: Percentile points of the posterior distributions on the ﬁxed-eﬀect terms in the CAR model.
2.5% 50% 97.5%
Intercept -2.2 -1.7 -1.2
Gender 0.31 0.46 0.58
Race 0.89 1.15 1.47
Age -0.051 -0.043 -0.034
CAR precision 0.19 0.36 0.64
decreasing abuse rates over time, so that three diﬀerent surveillance methods may be compared
with respect to their power to detect change.
Table 1 shows posterior credible regions (the Bayesian analogue of conﬁdence intervals) on the
coeﬃcients for gender, race, and age. The estimate for the gender coeﬃcient is 0.46 and the credible
region excludes 0, so women are less likely to abuse opioid drugs. Also, the coeﬃcient of 1.15 for
race means that Whites are more likely to abuse opioids than non-Whites. And the age coeﬃcient
is negative, so older people are less likely to abuse.
The location terms bk are random state eﬀects, and correlated. Since data are aggregated
by state, the correlation structure is coarse: two states directly interact if they are contiguous;
otherwise, states are conditionally independent given their neighbors. (Alaska is the only state in
the OTP data that has no neighbors.) The model for the correlation is multivariate Gaussian with
unknown but common correlation for states that share boundaries.
Figure 2 shows estimates of the state eﬀects in the CAR model. Three states with large positive
eﬀects were Tennessee, West Virginia, and Virginia. This accords with previous reports of high
opioid abuse rates in Appalachia. Some states, such as California and Connecticut, have lower
than expected rates of opioid abuse. The wide interval for Louisiana surely reﬂects uncertainty in
the data due to Hurricane Katrina; Texas also has a wide interval, perhaps from a combination of
evacuee spillover and the impact of Hurricane Rita.
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Figure 2: A display of the 95% credible regions on the location eﬀect. If the span of the line segment
for a state straddles zero on the y-axis, then there is more than a 5% chance that that state has no
eﬀect on the abuse rate, after accounting for gender, race and age. The central boxes contain the
middle 50% of the probability mass for the magnitude of the state eﬀect, and the midline within
the box is the point estimate of the magnitude of the state eﬀect.
The CAR model used in this analysis is substantially simpler than the one needed for general
disease surveillance. In particular, the geography is coarse and there is no temporal neighborhood
structure. However, it succeeds in discovering known patterns of opioid drug abuse and known
relationships with such covariates as age, gender, and race.
3.2 Power Comparisons
We now assess power in terms of change detection for a one-sided alternative which speciﬁes that
the drug abuse rate has decreased over time. This case is simpler than two-sided alternatives,
20reﬂects federal interest in measuring the eﬀectiveness of drug prevention programs, and the results
extend directly to the symmetric hypothesis that drug abuse has increased.
Using the data from the OTP component of RADARS R  , we explore power by simulation. For
each of three diﬀerent surveillance procedures, we examine power as a function of simulated levels of
abuse reduction. The simulations were performed by bootstrapping (Efron, 1979) from the original
data sets, after adjustment to achieve speciﬁed reduction levels. Speciﬁcally,
1. a generative model is assumed and ﬁt for the data;
2. simulations with artiﬁcial signal are generated from this model; and
3. the CAR, CUSUM, and paired-diﬀerence techniques are applied to the resulting data.
The generative model for the simulated OTP data is a CAR model that includes covariates as
estimated previously, but modiﬁed to create user-speciﬁed levels of decrease in drug abuse, thereby
enabling power comparisons for known levels of signal.
The three surveillance procedures that we compare are:
• A paired-diﬀerence two-sample test, which looks for diﬀerences in abuse rates over time at
each reporting MMTP site.
• A sequential process control procedure, using the CUSUM chart, similar to that used by the
CDC (Rolka et al., 2007).
• A CAR model which incorporates covariates as well as a geographic correlation.
These methods are compared with respect to their power in detecting simulated signal using his-
torical abuse data.
3.2.1 Paired-Diﬀerence and CUSUM Tests.
A two-sample test looks for a change between two time points. We use the traditional one-sided
test for a diﬀerence in binomial proportions. The test statistic is:
z = (ˆ p1 − ˆ p2)/
 
ˆ p1(1 − ˆ p1)
n1
+
ˆ p2(1 − ˆ p2)
n2
where ˆ p1 is the observed proportion of opioid abusers in the previous quarter and ˆ p2 is the observed
proportion in the current quarter. This test statistic is referred to a standard normal table.
21When the same sites report each time period, the two-sample test can be improved by pairing
the previous and current reports. Thus, if there are k such sites, then one can perform the two-
sample test separately at each, and pool the resulting P-values according to Fisher’s rule (Fisher,
1948). Let pi, for i = 1,...,k, be the P-value for site i; then
χ2
2k = −2
k  
i=1
lnpi
which is referred to a chi-squared table. Pairing allows many small reductions to be pooled to give
stronger evidence of an overall pattern of reduction. Repeated use requires adjustment for multiple
testing. To indicate geographical variation in the reductions, one can map P-values by region.
Control charts take a diﬀerent approach to syndromic surveillance. To decide whether a suc-
cession of observations has drifted away from a baseline value, a CUSUM chart plots the sum of
the diﬀerences between the previous quarters’ proportions and a baseline proportion. As described
in Montgomery (2001), when this sum falls below a lower control line, the result is statistically
signiﬁcant.
CUSUM charts assume that the baseline is ﬁxed and known. This may sometimes be reasonable
in manufacturing, but for drug surveillance, we do not know the baseline abuse rate; we can only
estimate this, with uncertainty, from historical data. The assumption of no trend in this historical
data is critical.
3.2.2 Simulation Procedures
The simulations in this study used data that were generated using the model in (3). The data
in the ﬁrst year was simulated using model parameters estimated from the ten quarters of OTP
data available in RADARS R  . The data in the second year was produced by multiplying those
means by the appropriate fraction to produce, on average, a linear decline in abuse during that
year, so that a user-speciﬁed reduction was achieved at the end of the year. The data in the
third year was simulated using the parameter values for the last quarter of the second year. The
baseline parameters used in these simulations were drawn from the posterior distributions for the
parameters estimated previously from the CAR model, shown in Table 1. We focus on power for
two signiﬁcance levels: α = .05 and α = .052 = .0025. These bracket loose and stringent levels for
Type I error. Each plotted point is based upon 200 simulations with a speciﬁc, simulated decrease
in opioid abuse from the historical record for OTP.
223.2.3 Results of the Power Analyses
Figure 3 shows the estimated power of the paired-diﬀerence two-sample test using OTP data with
Fisher’s test for change at MMTP clinics that appear in both time periods. This “blocking” of an
MMTP with itself automatically controls for many biases and reduces the variance in comparisons.
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Figure 3: Power curves for a two-sample OTP test. The most recent four quarters are combined
to give the pre-sample abuse level.
For control charts, one cannot plot power for all possible values of reduction (percentage de-
crease). So Figure 4 plots the probability of rejection for four diﬀerent reduction levels: 20%, 15%,
10% and 5%, reading the curves from left to right. Extensive pre-simulation runs were made to
determine the lower control line values for these charts; this was not trivial, and creating CUSUM
charts that attain speciﬁc false positive rates for observed baseline data is a drawback to this
surveillance approach. A CUSUM run was considered to signal if, at any of the twelve quarters of
simulated data, the cumulative sum fell below the lower control line.
Interpreting Figure 4 requires some care. Note that the two-sample tests compare a year’s worth
of initial data to a year’s worth of ﬁnal data (and ignores the transitional second year), whereas
the CUSUM test employs the original OTP data to establish the lower control limit and then uses
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Figure 4: Power curves for CUSUM testing with OTP data. The solid (broken) lines correspond
to .05 (.0025) level tests. The lines, reading from the bottom up, correspond to 5%, 10%, 15% and
20% reductions in abuse rate, pro-rated over three years.
three years of data, with all drift occurring in the second year (i.e., this is a piecewise linear trend).
Looking at the power in the last quarter gives a basis for comparison, but recall that control charts
do not adjust for multiple testing and that the CUSUM chart is exploiting partial signal available
in the second year.
To test for a drop in abuse rate, the CAR model in equation (3) is modiﬁed to include a
term for time. If the time coeﬃcient is signiﬁcantly less than zero, this indicates one-sided change
(reduction). The magnitude of the eﬀect can be estimated from the coeﬃcient.
The CAR model was ﬁt using Gibbs sampling run through WinBugs with an R interface. The
OTP data takes a relatively long time to run (about 10 minutes per simulation run) so the power
is only calculated for reductions of 1%, 2%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, and 12%, as shown in
Figure 5.
For OTP data, on a three-year horizon, the CUSUM appears more powerful than the CAR
test, which is more powerful than the two-sample test. But the CUSUM power is misleading—it
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Figure 5: Power curves for a CAR model test of abuse reduction using OTP data. The solid line
is for an alpha level of .05; the dashed line is for an alpha level of .0025.
is not directly comparable with the other procedures. The three-year time frame gives it a larger
eﬀective sample size than the CAR or two-sample tests; both of these make a single test, comparing
the historical data in the ﬁrst year to the simulated data in the third year, instead of the 12 tests
implicit in the CUSUM chart. With these caveats, Table 3 summarizes the estimated power of the
three procedures at the two diﬀerent α-levels for the simulated data.
There are other comparison issues besides the power. The two-sample test has the desirable
property of blocking on the reporting site, which controls for a potentially important source of vari-
ability. The CUSUM test requires a very precise estimate of the baseline, and there is considerable
diﬃculty in accounting for multiple testing. And the CAR test allows investigation of regional and
covariate eﬀects.
4 Conclusions
This paper has developed a high-end Bayesian approach to the problem of syndromic surveillance,
and illustrated some of the practical issues by applying the strategy to data on drug abuse surveil-
25Table 2: Estimated power for the Two-Sample test, the CUSUM test, and the CAR test, for
diﬀerent levels of reduction in the OTP abuse rate.
Percent Reduction Two-Sample CUSUM CAR
α = .05 α = .0025 α = .05 α = .0025 α = .05 α = .0025
5% .16 .02 .87 .55 .52 .16
10% .98 .67 .99 .99 .98 .93
15% .99 .99 .99 .99 .99 .99
20% .99 .99 .99 .99 .99 .99
lance. The results support the technical feasibility of the approach, with caveats as indicated below.
But a larger issue is political feasibility.
Bayesian methods are unpopular with federal agencies. There is a widespread misperception
that the use of prior information undercuts the scientiﬁc objectivity of the analysis—and it is true
that a partisan analyst could select a prejudicial prior, but that analysis would not withstand the
brief scrutiny of the professional community. On the other hand, Bayesian methods provide many
solid advantages: they follow from sensible axioms, unlike the hodgepodge of ad hoc frequentist
rules; they build on what one has learned, rather than approaching each question from the ex-
pensive posture of amnesia; and they provide clear probability statements, rather than the clumsy
locutions that deﬁne signiﬁcance probabilities and conﬁdence intervals. It is beyond the scope of
our paper to revisit this debate, but we emphasize that the statistical world has changed since
current administrators took their last course in basic statistics, and Bayesian methods are now
entirely uncontroversial and almost universally preferred.
But Bayesian methods require honest work. The application to drug abuse surveillance shows
that analysis on the scale needed for disease monitoring requires serious computational resources.
To accommodate the entire U.S. hospital system, our methods must be able to scale to at least
7,500 reporting units. The direct strategy is to partition the graph of hospitals into sets of cliques.
Updating within a clique may be done in alternation with updating across cliques. The schedule
26for the alternation is key to success, but there are general heuristics (e.g., rapid alternation at
ﬁrst, then slowing over time) which are useful. Since multiple MCMC chains can be started on
diﬀerent processors, a great deal of scalability can be achieved by parallel processing. This has
the disadvantage that burn-in time increases linearly with the number of processors. On the other
hand, recent solutions should provide very accurate approximations to the current posterior, and
researchers are developing smart ways to take advantage of this.
Besides computation, modeling requires care. The parameters of the prior distribution described
in (2) were been chosen to be ﬁxed (see Section 2.1.4). However, in practice these are unknown and
a source of uncertainty. A full hierarchical Bayesian approach would put priors on these parameters.
However, the normalizing constant Z(φ) can be intractable, since putting a prior distribution on φ
requires knowledge of Z(φ), which in turn requires evaluation of the numerator of (2) for all 2mT
possible values of δ(t),t = 1,...,T. In disease surveillance, we believe that a practical solution
can be built by assuming that all nodes within a city or subregion have the same main eﬀect
and interaction parameters. This multiplicity in the parameters makes it easier to calculate an
expression for the normalizing constant.
A positive point for the Bayesian approach is that decision theory approach can be built into
the syndromic surveillance system. A basic requirement for a useful surveillance system is that
its false alarm rate should be low and commensurate with the resources available for post-alarm
investigation. Unlike the scan statistic and other frequentist methods, in the Bayesian approach
it is possible to explicitly incorporate the resource matrix for all the hospitals and/or cities in the
decision process. While the consequence of a false alarm is not the same for all the locations,
the available resources for investigation or follow up of an alarm may not also be the same. We
recommend a decision-theoretic formulation following Scott and Berger (2006), Duncan (1965) and
Waller and Duncan (1969).
In short, the Bayesian approach has many desirable properties, in terms of power, interpretabil-
ity, and practicality. There are some technical issues that need resolution in order to monitor the
large datastreams expected in disease surveillance, but there are strategies to address these and
none seem insurmountable. There larger barriers are institutional—those will require imaginative
leadership.
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